Evaluation of P-glycoprotein (Pgp) expression in human osteosarcoma by high-throughput tissue microarray.

Area of Science:

• Orthopaedic Research
• Oncology
• Molecular Biology

Background:

• Osteosarcoma patient survival is hindered by metastasis and multidrug resistance (MDR).
• P-glycoprotein (Pgp) overexpression is a known cause of MDR, but its clinical significance in osteosarcoma requires further clarification.

Purpose of the Study:

• To investigate the correlation between Pgp expression and clinical behavior in osteosarcoma patients.
• To determine if Pgp expression is a predictor of metastasis and chemotherapy response in osteosarcoma.

Main Methods:

• High-throughput tissue microarray (TMA) analysis of Pgp expression.
• Immunohistochemical analysis of 114 osteosarcoma specimens.
• Retrospective review of 70 osteosarcoma patients from Massachusetts General Hospital (MGH).

Main Results:

• High Pgp expression was observed in 18 of 57 primary osteosarcoma patients.
• Patients with high Pgp expression showed increased metastasis development (72%) and poor response to pre-operative chemotherapy.
• No significant correlation was found between Pgp expression and overall osteosarcoma survival.

Conclusions:

• High Pgp expression is associated with aggressive clinical behavior in osteosarcoma, including metastasis and chemotherapy resistance.
• Pgp expression is an important factor but not an independent predictor of osteosarcoma survival.
• Further research is needed to fully understand the role of Pgp in osteosarcoma progression and treatment.